As New to The Street’s prestigious client, NRx’s progress was also acknowledged by Vince Caruso, Co-Founder and CEO of New to The Street, who stated: “NRx Pharmaceuticals is breaking new ground in ...
Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamine Granting of Suitability Petition ...
Granting of Suitability Petition enables re-filing of Abbreviated New Drug Application (ANDA) for NRx’s patent-pending preservative-free ketamine product NEW YORK, NY / ACCESS Newswire / September 24, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback